Dr. Matti Aapro continues to shape oncology with his latest work. In February 2025, he co-authored the MASCC antiemetic consensus recommendations in Supportive Care in Cancer, offering alternative regimens for managing chemotherapy-induced nausea and vomiting (CINV) in resource-limited settings, improving global patient care.
In January 2025, he was re-elected to the Board of Directors of the Union for International Cancer Control (UICC) for 2024–2026, reinforcing his leadership in global cancer policy. As President of Sharing Progress in Cancer Care (SPCC) and All.Can International, he continues to drive advancements in patient-centered oncology care.
Dr. Aapro’s work remains pivotal in supportive oncology, particularly for geriatric patients and those with limited treatment access. His dedication to improving cancer care worldwide is shaping the future of oncology.
Read more: https://lnkd.in/e5xEfzeu
https://lnkd.in/eg6b-gVC
